Day: February 7, 2024

Novartis Acquires Cancer-Focused MorphoSys for $2.9 Billion

February 7, 2024 : In a strategic move bolstering its presence in the lucrative cancer treatment market, pharmaceutical giant Novartis has agreed to acquire